Arcturus Therapeutics Holdings Inc (NASDAQ:ARCT) price on Thursday, July 03, rose 1.17% above its previous day’s close as an upside momentum from buyers pushed the stock’s value to $13.78.
A look at the stock’s price movement, the close in the last trading session was $13.62, moving within a range at $13.44 and $13.9399. The beta value (5-Year monthly) was 2.291. Turning to its 52-week performance, $25.88 and $8.04 were the 52-week high and 52-week low respectively. Overall, ARCT moved 6.00% over the past month.
Arcturus Therapeutics Holdings Inc’s market cap currently stands at around $373.72 million, with investors looking forward to this quarter’s earnings report slated for on 2025-May-12.
Turning to the stock’s technical picture we see that short term indicators suggest on average that ARCT is a Hold. On the other hand, the stock is on average a 50% Sell as suggested by medium term indicators while long term indicators are putting the stock in 50% Sell category.
6 analyst(s) have given their forecast ratings for the stock on a scale of 1.00-5.00 for a strong buy to strong sell recommendation. A total of 0 analyst(s) rate the stock as a Hold, 5 recommend ARCT as a Buy and 0 give it an Overweight rating. Meanwhile, 0 analyst(s) rate the stock as Underweight and 1 say it is a Sell. As such, the average rating for the stock is Buy which could provide an opportunity for investors keen on increasing their holdings of the company’s stock.
ARCT’s current price about 6.66% and 10.47% off the 20-day and 50-day simple moving averages respectively. The Relative Strength Index (RSI, 14) currently prints 58.15, while 7-day volatility ratio is 9.01% and 7.25% in the 30-day chart. Further, Arcturus Therapeutics Holdings Inc (ARCT) has a beta value of 2.27. Analysts have given the company’s stock an average 52-week price target of $40, forecast between a low of $32 and high of $48. Looking at the price targets, the low is -132.22% off current price level while to achieve the yearly target high, price needs to move -248.33%. Nonetheless, investors will most likely welcome a -190.28% jump to $40 which is the analysts’ median price.
If we refocus on Arcturus Therapeutics Holdings Inc (NASDAQ:ARCT), historical trading data shows that trading volumes averaged 0.54 over the past 10 days and 464.92K over the past 3 months. The company’s latest data on shares outstanding shows there are 27.12 million shares.
The 8.44% of Arcturus Therapeutics Holdings Inc’s shares are in the hands of company insiders while institutional holders own 91.62% of the company’s shares. Also important is the data on short interest which shows that short shares stood at 4.97 million on 2025-06-13, giving us a short ratio of 10.37. The data shows that as of 2025-06-13 short interest in Arcturus Therapeutics Holdings Inc (ARCT) stood at 2832.0 of shares outstanding, with shares short falling to 5.41 million registered in 2025-05-15. Current price change has pushed the stock -41.76% YTD, which shows the potential for further growth is there. It is this reason that could see investor optimism for the ARCT stock continues to rise going into the next quarter.
